Shares of HIMS experienced a dramatic decline today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending the company's stock price plummeting by over fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts specul